Phathom Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2021-06-02

Reporting Person: TAKEDA PHARMACEUTICAL CO LTD (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-02	Common Stock	S	4300	$35.18	Disposed	944369	Direct

Footnotes

F1: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.

F2: Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.04 to $35.87. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.